A Milestone for Cancer Research Funding
The T.J. Martell Foundation successfully concluded its 51st Annual New York Honors Gala at Cipriani 42nd Street, raising more than $3.2 million to support critical cancer research. According to MusicRow, this year’s total marks the organization’s most successful fundraising performance in more than two decades, signaling a robust start to its next 50 years of operations.
The event was led by Steve Gawley, Chair of the Foundation’s Board of Trustees and Executive Vice President of Business & Legal Affairs at REPUBLIC Collective. The gala featured a significant industry presence, with key members of the Foundation’s Executive Committee, including representatives from Warner Music Group, Universal Music Group, and SoundExchange, in attendance to support the initiative.
Honoring Industry Philanthropy
A central focus of the evening was the presentation of the Lifetime Music Industry Award to Red Light Management founder Coran Capshaw. The award was presented by musician Dave Matthews, who, along with Trey Anastasio and Chris Stapleton, performed in Capshaw’s honor.
During his remarks, Capshaw emphasized the music industry’s unique capacity to mobilize resources during crises, noting that the sector consistently steps up to support community needs, from disaster relief to health initiatives. “What really unites this room, both the musicians and the business side alike, is our industry’s inclination to do good and to give back,” Capshaw stated.
Impact on Clinical Research
The funds raised are earmarked for high-risk, high-reward research initiatives that aim to accelerate drug discovery and advance clinical trials. Steve Gawley noted that the capital provides scientists with the necessary resources to pursue promising, albeit ambitious, ideas that might otherwise struggle for funding. The goal remains to provide patients with improved treatment options and, ultimately, more time with their families.
The foundation’s leadership confirmed that the success of this year’s gala sets a high benchmark for future fundraising efforts, as the organization looks toward the next half-century of supporting medical breakthroughs.